End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.56 CNY | +1.18% | +2.64% | -18.48% |
Mar. 20 | Biggest cyberattacks in US healthcare sector | RE |
Feb. 29 | US Commerce Department Conducts Anti-Dumping Probe on Healthcare Co.'s Global Bases | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The company is in debt and has limited leeway for investment
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Home Furnishings
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.48% | 674M | - | ||
-2.06% | 8.67B | B | ||
-4.20% | 3.79B | C- | ||
+5.08% | 2.22B | C | ||
+6.69% | 1.8B | - | ||
-10.32% | 1.41B | B- | ||
-27.03% | 1.18B | C+ | ||
+28.08% | 1.13B | - | ||
+4.35% | 928M | - | ||
-2.98% | 816M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603313 Stock
- Ratings Healthcare Co.,Ltd.